Evidence map›Paper›PMID 15475363›Full record

ArticleThe Journal of biological chemistry2005

Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.

Barry B Rubin, Gregory P Downey, Adeline Koh, Norbert Degousee, Farideh Ghomashchi, Laxman Nallan, Eva Stefanski, Denis W Harkin, Chunxiang Sun, Brian P Smart and 11 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 102 citations in OpenAlex.

  1. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The phospholipase AJournal of lipid research · 2018
    Review
  10. Lipidomics in translational research and the clinical significance of lipid-based biomarkers.Translational research : the journal of laboratory and clinical medicine · 2017
    Review
  11. Cytosolic Phospholipase AInfection and immunity · 2017
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. The ubiquitin-CXCR4 axis plays an important role in acute lung infection-enhanced lung tumor metastasis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Barry B RubinDivision of Vascular Surgery and Toronto General Hospital Research Institute of the University Health Network, University of Toronto, Toronto, Ontario M5G 2C4, Canada. barry.rubin@uhn.on.ca
Gregory P Downey
Adeline Koh
Norbert Degousee
Farideh Ghomashchi
Laxman Nallan
Eva Stefanski
Denis W Harkin
Chunxiang Sun
Brian P Smart
Thomas F Lindsay
Vera Cherepanov
Eric Vachon
David Kelvin
Martin Sadilek
Glenn E Brown
Michael B Yaffe
Jonathan Plumb
Sergio Grinstein
Michael Glogauer
Michael H Gelb
University of Toronto · CAUniversity of Washington · USUniversity Health Network · CAToronto General Hospital · CACenter for Cancer Research · USHospital for Sick Children · CA

Funding

NEUTROPHIL PRIMING IN TRAUMA AND SEPSISR01GM059281 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1999 to 2011
$4.2M
Regulation and Function of Cytosolic Phospholipase A2R01HL050040 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 1993 to 2012
$2.4M
STUDIES IN ENZYMOLOGY USING INHIBITORSR01HL036235 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 1989 to 2006
$2.1M
NHLBI NIH HHS HL36236NHLBI NIH HHS HL50040NHLBI NIH HHS R01 HL036235NHLBI NIH HHS R01 HL050040NIGMS NIH HHS GM59281NIGMS NIH HHS R01 GM059281
6 · The paper itself

Abstract

The role of a cytosolic phospholipase A(2)-alpha (cPLA(2)-alpha) in neutrophil arachidonic acid release, platelet-activating factor (PAF) biosynthesis, NADPH oxidase activation, and bacterial killing in vitro, and the innate immune response to bacterial infection in vivo was examined. cPLA(2)-alpha activity was blocked with the specific cPLA(2)-alpha inhibitor, Pyrrolidine-1 (human cells), or by cPLA(2) -alpha gene disruption (mice). cPLA(2)-alpha inhibition or gene disruption led to complete suppression of neutrophil arachidonate release and PAF biosynthesis but had no effect on neutrophil NADPH oxidase activation, FcgammaII/III or CD11b surface expression, primary or secondary granule secretion, or phagocytosis of Escherichia coli in vitro. In contrast, cPLA(2)-alpha inhibition or gene disruption diminished neutrophil-mediated E. coli killing in vitro, which was partially rescued by exogenous arachidonic acid or PAF but not leukotriene B(4). Following intratracheal inoculation with live E. coli in vivo, pulmonary PAF biosynthesis, inflammatory cell infiltration, and clearance of E. coli were attenuated in cPLA(2)-alpha(-/-) mice compared with wild type littermates. These studies identify a novel role for cPLA(2)-alpha in the regulation of neutrophil-mediated bacterial killing and the innate immune response to bacterial infection.

Indexed as

AnimalsArachidonic AcidBronchoalveolar Lavage FluidCD11b AntigenCytosolDose-Response Relationship, DrugEscherichia coliGroup IV Phospholipases A2HumansInflammationIonomycinLeukotriene B4MiceMice, TransgenicNADPH OxidasesNeutrophilsArachidonic AcidCD11b AntigenGroup IV Phospholipases A2IonomycinLeukotriene B4NADPH OxidasesOxygenPhospholipases APhospholipases A2Platelet Activating FactorpyrrolidinePyrrolidinesReceptors, IgGTumor Necrosis Factor-alpha

Identifiers

PMID15475363
PMCPMC2409062
OpenAlexW2121474571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.